MeVis Medical Solutions(GB:0HI7)
€22.000.00 (0.00%)
GB:0HI7
MeVis Medical Solutions financials statements
€22.00
At close:0.00 (0.00%)
MeVis Medical Solutions (0HI7) Ratios
0 Followers
MeVis Medical Solutions Ratios
GB:0HI7's free cash flow for Q2 2026 was €0.00. For the 2026 fiscal year, GB:0HI7's free cash flow was increased by €0.00 and operating cash flow was €0.00. See a summary of the company’s cash flow.
| Ratios | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.58 | 1.50 | 1.66 | 1.50 | 1.62 |
| Quick Ratio | 1.58 | 1.50 | 1.66 | 1.49 | 1.61 |
| Cash Ratio | 1.14 | 1.03 | 1.13 | 0.96 | 1.14 |
| Solvency Ratio | 0.41 | 0.54 | 0.49 | 0.59 | 0.48 |
| Operating Cash Flow Ratio | 0.68 | 0.49 | 0.85 | 0.50 | 1.36 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | € 992.23K | € 890.18K | € 1.14M | € 1.13M | € 1.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.45 | 1.49 | 1.57 | 1.75 | 1.54 |
| Debt Service Coverage Ratio | 5741.98 | 239.22 | 118.12 | 0.00 | 432.68 |
| Interest Coverage Ratio | 4058.20 | 204.00 | 150.47 | 0.00 | 596.20 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.02 | 0.00 | 0.01 |
| Net Debt to EBITDA | -1.90 | -1.35 | -1.50 | -1.17 | -1.60 |
| Profitability Margins | |||||
| Gross Profit Margin | 97.70% | 97.11% | 40.38% | 96.02% | 97.31% |
| EBIT Margin | 20.42% | 27.73% | 29.27% | 42.00% | 28.63% |
| EBITDA Margin | 21.33% | 28.40% | 29.83% | 42.48% | 29.40% |
| Operating Profit Margin | 14.58% | 23.58% | 37.16% | 33.53% | 39.79% |
| Pretax Profit Margin | 20.41% | 27.62% | 29.03% | 41.98% | 28.56% |
| Net Profit Margin | 19.71% | 26.87% | 28.37% | 41.52% | 28.04% |
| Continuous Operations Profit Margin | 19.71% | 26.87% | 28.37% | 41.52% | 28.04% |
| Net Income Per EBT | 96.56% | 97.30% | 97.73% | 98.89% | 98.16% |
| EBT Per EBIT | 140.02% | 117.12% | 78.12% | 125.21% | 71.78% |
| Return on Assets (ROA) | 12.23% | 17.22% | 17.54% | 24.96% | 16.51% |
| Return on Equity (ROE) | 17.76% | 25.59% | 27.60% | 43.69% | 25.50% |
| Return on Capital Employed (ROCE) | 11.61% | 19.89% | 30.39% | 29.22% | 30.96% |
| Return on Invested Capital (ROIC) | 11.16% | 19.44% | 29.70% | 28.90% | 30.39% |
| Return on Tangible Assets | 12.23% | 17.22% | 17.54% | 24.96% | 16.51% |
| Earnings Yield | 7.01% | 10.90% | 9.52% | 12.51% | 7.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.05 | 6.14 | 6.54 | 3.85 | 5.59 |
| Payables Turnover | 2.57 | 5.73 | 134.73 | 3.88 | 1.82 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 5.59 | 4.36 |
| Fixed Asset Turnover | 52.02 | 53.84 | 118.73 | 115.80 | 133.13 |
| Asset Turnover | 0.62 | 0.64 | 0.62 | 0.60 | 0.59 |
| Working Capital Turnover Ratio | 4.92 | 4.40 | 3.71 | 4.16 | 4.18 |
| Cash Conversion Cycle | -90.44 | -4.27 | 53.11 | 65.86 | -51.34 |
| Days of Sales Outstanding | 51.78 | 59.46 | 55.81 | 94.76 | 65.26 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 65.24 | 83.72 |
| Days of Payables Outstanding | 142.22 | 63.74 | 2.71 | 94.15 | 200.32 |
| Operating Cycle | 51.78 | 59.46 | 55.81 | 160.00 | 148.98 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.13 | 1.73 | 3.22 | 2.67 | 5.02 |
| Free Cash Flow Per Share | 2.05 | 1.56 | 3.17 | 2.60 | 4.99 |
| Dividend Paid and CapEx Coverage Ratio | 0.83 | 0.60 | 0.74 | 1.04 | 1.59 |
| Capital Expenditure Coverage Ratio | 27.62 | 10.42 | 73.44 | 36.49 | 179.53 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.24 | 0.19 | 0.34 | 0.26 | 0.56 |
| Free Cash Flow Yield | 8.28% | 6.80% | 11.17% | 7.59% | 15.30% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.25 | 9.18 | 10.51 | 7.99 | 13.05 |
| Price-to-Sales (P/S) Ratio | 2.81 | 2.47 | 2.98 | 3.32 | 3.66 |
| Price-to-Book (P/B) Ratio | 2.53 | 2.35 | 2.90 | 3.49 | 3.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 12.07 | 14.72 | 8.95 | 13.18 | 6.53 |
| Price-to-Operating Cash Flow Ratio | 11.64 | 13.30 | 8.83 | 12.81 | 6.50 |
| Price-to-Earnings Growth (PEG) Ratio | -0.46 | -1.30 | -0.28 | 0.11 | -0.65 |
| Enterprise Value Multiple | 11.27 | 7.33 | 8.50 | 6.64 | 10.85 |
| Enterprise Value | 38.61M | 35.33M | 43.94M | 52.92M | 51.71M |
| EV to EBITDA | 11.27 | 7.33 | 8.50 | 6.64 | 10.85 |
| EV to Sales | 2.40 | 2.08 | 2.53 | 2.82 | 3.19 |
| EV to Free Cash Flow | 10.33 | 12.42 | 7.61 | 11.20 | 5.69 |
| EV to Operating Cash Flow | 9.95 | 11.23 | 7.51 | 10.90 | 5.66 |
| Tangible Book Value Per Share | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 |
| Shareholders’ Equity Per Share | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.03 | 0.02 | 0.01 | 0.02 |
| Revenue Per Share | 8.82 | 9.33 | 9.53 | 10.31 | 8.91 |
| Net Income Per Share | 1.74 | 2.51 | 2.70 | 4.28 | 2.50 |
| Tax Burden | 0.97 | 0.97 | 0.98 | 0.99 | 0.98 |
| Interest Burden | 1.00 | 1.00 | 0.99 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.03 | 0.03 | 0.02 | 0.05 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.23 | 0.69 | 1.19 | 0.62 | 2.01 |
Currency in EUR

